In plain words
Four randomized trials, each lasting a few months, found lower cholesterol or triglycerides with berberine than with placebo, lifestyle change or metformin. Two studies without a comparison group also saw levels fall. The trials were small and short.
The short answer
All four randomized trials, lasting 3 months to 16 weeks, found lower lipids with berberine against placebo, metformin or lifestyle change: 116 people on 1.0 g a day (2008), 59 and 61 women with PCOS with no dose in the ledger (2011), 184 people (2015) and 36 people (2008) on 500 mg three times a day. Two before-after studies with no control group, in 32 and 48 people over 3 months, saw falls too. Certainty is low, because the trials are small and short.
Where the evidence sits
Lipids fell
No significant change
■ measured by the source's own study · ◪ pooled analysis, may overlap studies counted here · □ reported, reviewed or argued, no new data
Who says what
| Source | Finding | Design | People | Dose and length | Funding and independence |
|---|---|---|---|---|---|
| Zhang et al., 2008 | Lower cholesterol | Randomized, against placebo | 116 | 1.0 g a day, 3 months | Not in ledger |
| Wei et al., 2011 | Lower cholesterol and triglycerides | Randomized, against placebo and metformin | 59 and 61 women with PCOS | 3 months; dose not in ledger | Not in ledger |
| Yan et al., 2015 | Larger falls than lifestyle change | Randomized, against lifestyle change | 184 | 16 weeks | Not in ledger |
| Yin et al., 2008 | Lower than metformin; fell from baseline as add-on | Randomized, against metformin; separate before-after study | 36; 48 | 500 mg three times a day, 13 weeks; 3 months | Not in ledger |
| Kong et al., 2004 | Fell from baseline | Before-after study, no control group | 32 | 3 months | Not in ledger |
| Dong et al., 2012 | Lower with lifestyle change; no significant change added to diabetes drugs | Meta-analysis that may include the trials above | 271 in one comparison | 12 weeks in one comparison | Not in ledger |
| Dong et al., 2013 | Lower cholesterol | Meta-analysis that may include the trials above | 874 | Not in ledger | Not in ledger |
Lower cholesterol
Lower cholesterol and triglycerides
Larger falls than lifestyle change
Lower than metformin; fell from baseline as add-on
Fell from baseline
Lower with lifestyle change; no significant change added to diabetes drugs
Lower cholesterol
What did the randomized trials find?
Zhang and colleagues (2008) gave 116 people 1.0 g of berberine a day or placebo for 3 months, and total cholesterol fell in the berberine group:
total cholesterol from 5.31 +/- 0.98 to 4.35 +/- 0.96 mm/liter
Wei and colleagues (2011) compared berberine with placebo in 59 women with PCOS and with metformin in 61 over 3 months, with no dose in the ledger; lipids favored berberine both times. Yan and colleagues (2015) report larger falls in triglycerides and cholesterol than with lifestyle change alone, in 184 people over 16 weeks. Yin and colleagues (2008) found triglycerides and total cholesterol lower than with metformin in 36 people on 500 mg three times a day for 13 weeks.
What did studies without a control group find?
Kong and colleagues (2004) measured 32 people with high cholesterol before and after 3 months of berberine, with no dose in the ledger:
Oral administration of BBR in 32 hypercholesterolemic patients for 3 months reduced serum cholesterol by 29%, triglycerides by 35% and LDL-cholesterol by 25%.
In a separate before-after study, Yin and colleagues (2008) gave 500 mg three times a day as add-on therapy to 48 people, and after 3 months lipids were below baseline.
Do the meta-analyses agree?
Both meta-analyses pooled trials that may include the trials above. Dong and colleagues (2012) found lower triglycerides and LDL when berberine joined lifestyle change (271 people, 12 weeks, no dose in the ledger), and no significant change in the trials that added it to diabetes drugs. Dong and colleagues (2013) pooled randomized trials in 874 people, with no dose or duration in the ledger, and concluded:
In conclusion, berberine may have beneficial effects in the control of blood lipid levels.
Why the sources disagree
The independent studies point the same way. The one result without a significant change is in Dong and colleagues (2012), a pooled estimate that may include the trials above, where berberine was added to diabetes drugs rather than tested against placebo, metformin or lifestyle change. The people also differ: women with PCOS (2011) and people with high cholesterol (2004). The longest trial ran 16 weeks.
What would settle it
An independently funded, pre-registered randomized trial of berberine at 1.0 g a day against placebo in adults with high LDL cholesterol, lasting 12 months and reporting LDL, triglycerides and HDL at 3, 6 and 12 months. A lasting LDL difference repeated by a second research group would raise certainty above low; no difference at 12 months would weaken the shorter trials.
How this page was made
The 7 sources were chosen from a PubMed search: five that measured blood lipids in people directly and two meta-analyses that may include their trials. Four search results were left out because they studied cells and animals, other diseases, or a berberine salt. Every claim was copied word for word into the Longevity Circle ledger and checked against the original text, and a person approved each one. Certainty follows the GRADE levels used in medical reviews. Drafting was assisted by AI.
Changelog: 30 Sep 2026, first version, 7 sources.
